ArticleFrontiers in pharmacology2025

Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center.

Naama Lax et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.